The NIH Early Stage Investigator (ESI) designation is given to researchers who have not served as a PI on an R01 or equivalent and who are 10 years or less from their terminal degree (e.g., PhD) or last clinical training/fellowship. ESI status confers a funding advantage, sometimes a significant one. Protecting that status is an […]
Misrouting happens, but it’s often preventable. Here are some reasons why it might have happened: 1- You let CSR choose the study section. While it may be tempting to let the Center for Scientific Review’s (CSR) algorithm determine your study section assignment, that approach carries risk. The algorithm won’t invest the time and care that
Why didn’t I get the study section I wanted for my NIH application review? Read More »
When an applicant comes to me for advising, one of the first questions I have is about their ESI expiration, so that we can map out a long-term strategy to maximize this funding advantage, if relevant. For early-career biomedical researchers, few designations carry as much practical weight as the NIH Early Stage Investigator (ESI) status.
